17 min

Safeguarding the CKD Patient With or Without Diabetes in Primary Care: Quick Questions, Rapid Replies Keeping Current

    • Medicine

Did you know that SGLT2 blockade can reduce progression to ESKD by at least a decade in patients with mild-to-moderately decreased eGFR?
Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990093?ecd=bdc_podcast_libsyn_mscpedu

Did you know that SGLT2 blockade can reduce progression to ESKD by at least a decade in patients with mild-to-moderately decreased eGFR?
Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990093?ecd=bdc_podcast_libsyn_mscpedu

17 min

More by Medscape

This Week in Cardiology
Medscape
Medicine and the Machine
Medscape
Keeping Current
Medscape Podcasts
Keeping Current CME
Medscape
One-on-One with Eric Topol
Medscape
The Bob Harrington Show
Medscape